| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.666 | 404 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Income - EUR | 13.296 | 404 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | 28.085 | 7.144 | 1.002 | 2.526 | 2.363 | 8.270 | 1.278 | 0 | - | - |
| Gross Profit/Loss - EUR | -14.789 | -6.740 | -1.002 | -2.526 | -2.363 | -8.270 | -1.278 | 0 | - | - |
| Net Profit/Loss - EUR | -15.188 | -6.744 | -3.157 | -2.526 | -2.363 | -8.270 | -1.278 | 0 | - | - |
| Employees | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Opus Pharm Live Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.611 | 880 | 475 | 358 | 307 | 0 | 0 | 0 | - | - |
| Current Assets | 6.547 | 6.152 | 6.058 | 5.937 | 5.831 | 195 | 190 | 191 | - | - |
| Inventories | 6.523 | 5.943 | 5.852 | 5.735 | 5.633 | 0 | 0 | 0 | - | - |
| Receivables | 0 | 210 | 206 | 202 | 199 | 195 | 190 | 191 | - | - |
| Cash | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Shareholders Funds | -35.333 | -41.716 | -44.167 | -45.883 | -47.357 | -54.729 | -54.793 | -54.963 | - | - |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | - | - |
| Debts | 44.041 | 49.293 | 51.237 | 52.705 | 54.012 | 54.924 | 54.984 | 55.154 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Opus Pharm Live Srl